At its Q3 2026 results briefing Hengtong said it will deepen internal synergies and resource integration within its biotech unit to boost product competitiveness, and will monitor external niche technology and product opportunities, focusing on key i

2026-11-10

At its Q3 2026 results briefing Hengtong said it will deepen internal synergies and resource integration within its biotech unit to boost product competitiveness, and will monitor external niche technology and product opportunities, focusing on key industry‑chain links and emerging technologies, with opportunistic partnerships or investments to complete its industry layout.